Denis Dufrane

Denis Dufrane is co-founder, CEO, and Chief Scientific Officer of Novadip Biosciences, a Walloon regenerative medicine company developing adipose stem cell-based therapies for bone defects, spun out of UCLouvain and Saint-Luc University Hospital.

1 News mention

Overview

Dufrane received his medical degree and doctorate in biomedical sciences from UCLouvain and was previously head of the Musculoskeletal Tissue Bank and Tissue/Cells Therapy Centre at Saint-Luc University Hospital in Brussels. He co-founded Novadip in 2013 and joined full-time in 2015. The company's 3M3 tissue regeneration platform uses adipose-derived stem cells, and has raised EUR 88 million in total funding including EUR 40 million in a 2022 round and a subsequent EIB venture debt tranche under InvestEU.

Career history

  1. FounderNovadip Biosciences

In the news

This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.